Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J. G.
Right arrow Articles by Olefsky, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J. G.
Right arrow Articles by Olefsky, J. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:1941-1942, 2003
© 2003 by the American Diabetes Association, Inc.


Letters: Observations
Letter

The Effect of Oral Glucosamine Sulfate on Insulin Sensitivity in Human Subjects

Joseph G. Yu, MD1,2,3, Sarah M. Boies, BS1,2,3 and Jerrold M. Olefsky, MD1,2,3

1 Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California
2 Veterans Administration San Diego Healthcare System, San Diego, California
3 The Whittier Institute for Diabetes, La Jolla, California

The first 20% of the full text of this article appears below.

As glucosamine is presently in wide use due to its purported beneficial effects in patients with osteoarthritis, it seemed important to consider its possible adverse effects on glucose metabolism. Many subjects who take glucosamine for osteoarthritis are obese, insulin resistant, diabetic, or at risk for the development of diabetes, and it is established that glucosamine induces insulin resistance in rats and mice. Hypotheses suggest that glucosamine causes insulin resistance by directly entering the hexosamine biosynthetic pathway. It has been proposed that this provides a model for glucotoxicity-induced defects in insulin action and secretion (1), since, under hyperglycemic conditions, a larger amount of glucose flux is metabolized through the hexosamine pathway. Therefore, we undertook this study to determine if glucosamine, taken at recommended doses for the treatment of osteoarthritis, had . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
B A Biggee, C M Blinn, M Nuite, J E Silbert, and T E McAlindon
Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis
Ann Rheum Dis, February 1, 2007; 66(2): 260 - 262.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Muniyappa, R. J. Karne, G. Hall, S. K. Crandon, J. A. Bronstein, M. R. Ver, G. L. Hortin, and M. J. Quon
Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects
Diabetes, November 1, 2006; 55(11): 3142 - 3150.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. L Stumpf and S.-W. Lin
Effect of Glucosamine on Glucose Control
Ann. Pharmacother., April 1, 2006; 40(4): 694 - 698.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. Boullata
Natural Health Product Interactions with Medication
Nutr Clin Pract, February 1, 2005; 20(1): 33 - 51.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.